← Back to Recovery & peptides

Recovery & peptides · Comparison

Research-use-only vs. pharmacy-compounded BPC-157: why the label matters now

Before October 28, most BPC-157 in circulation came in vials labeled “not for human use.” The new policy draws a hard line between those and pharmacy-compounded product.

Reader noteTreatment decisions belong with a licensed clinician who knows your history.

THE BOTTOM LINE

Pharmacy-compounded BPC-157 is made for one patient on a prescription, from an FDA-registered source with a certificate of analysis, and labeled and tracked. A research-use-only vial is sold with no prescriber, no verified source and no safety reporting, and the October 28 policy does nothing for it. Independent testing of gray-market peptide vials has found under-dosed and mislabeled product.

What actually differs

FactorPharmacy-compoundedResearch-use-only
Made forOne patient, on a prescription“Laboratory research”
Ingredient sourceFDA-registered, CGMP manufacturer, certificate of analysisUsually undisclosed
OversightState board of pharmacy, prescriberNone
SterilityPharmacy compounding standards applyUnknown
Adverse-event reportingSerious events go to FDA MedWatchNone
Covered by Oct 28 policyYes, if conditions are metNo

Why research vials were everywhere

Until October 2026, BPC-157 sat on FDA's list of bulk substances with significant safety concerns, so licensed pharmacies largely stopped compounding it. Demand moved to websites selling lyophilized vials labeled for research only. Buyers took on the risk of identity, dose and sterility themselves.

What the policy requires of compounded product

The ingredient must come from an FDA-registered facility with a valid certificate of analysis, made by a CGMP-compliant manufacturer. The product must contain only one active ingredient, use a listed route, carry the required label, and come with a 510(k)-cleared syringe if injected. Those conditions are exactly what research vials can't show.

If you already use research vials

Don't change anything abruptly without talking to a clinician, and be honest with them about what you've used. The safer path is a clinician who can decide whether BPC-157 makes sense for you at all and, if it does, a pharmacy you can name.

Is research-grade BPC-157 the same as compounded BPC-157?

It may be the same molecule, but the source, purity, sterility and oversight are not verified. Only pharmacy-compounded BPC-157 that meets the HHS conditions is covered by the October 28 policy.

Check the underlying record

Federal Register: HHS enforcement discretion policy, 503A peptide compounding (public inspection)↗HHS policy appendix B (PDF)↗Frier Levitt: what the peptide policy covers, by route↗FDA: Safety risks with certain bulk drug substances↗
Regulatory status and labeling can change. Sources were reviewed on the article update date; current prescribing information controls.

Live Vital

A physician-supervised telehealth company offering compounded BPC-157 under the October 28 policy, with treatment decisions made by a licensed clinician. Run it through the seven questions on our BPC-157 review before you start.

Check BPC-157 eligibility at Live Vital →Televetted may earn a commission if you sign up through this link. Payment never changes the facts we report. This is not a rating under the Televetted Method.
Evidence reviewBPC-157 after the October 28 policy: what changed, what didn't, and how to check a providerLegal statusIs BPC-157 legal now? The honest answer after October 28How toHow to get BPC-157 through telehealth, and what a legitimate provider looks likeClaim checkThe BPC-157 + TB-500 “Wolverine stack” is not covered by the new policyComparisonOral vs. injectable BPC-157: which forms the policy covers, and what to ask

Medication is only one part of the decision.

Use the 30-second filter to identify the costs, clinical safeguards and service terms worth checking before you enroll.

Find my starting point →